TPP生物制品数据保护条款与中国政策定位研究

发布时间：2018-06-08 12:12

  本文选题：TPP + 生物制品数据保护　； 参考：《上海医药》2016年17期

【摘要】：本文从《跨太平洋伙伴关系协议》(TPP)生物制品数据保护条款出发,在剖析条款要点与制度效应基础上,根据产业发展水平探究我国生物制品数据保护政策定位问题。研究发现,现阶段我国创新投入水平和居民支付能力与生物制品数据保护制度并不匹配,实施该制度的负效应将大正效应。建议我国在完善产业配套制度、促进产业转型升级的同时,审时度势,谨慎分析利弊,并设计相应谈判策略预案。
[Abstract]:In this paper, based on the data protection provisions of TPP- (Trans-Pacific Partnership Agreement), based on the analysis of the key points of the terms and the institutional effects, this paper probes into the policy orientation of the data protection of biological products in China according to the level of industrial development. It is found that the level of innovation input and residents' ability to pay in China do not match with the data protection system of biological products at the present stage, and the negative effects of the system will be positive. It is suggested that our country should, while perfecting the supporting system of industry and promoting industrial transformation and upgrading, review the situation, carefully analyze the pros and cons, and design the corresponding negotiation strategy plan.
【作者单位】： 中国药科大学;
【基金】：国家社会科学基金《TRIPS框架下中国药品试验数据保护制度研究》(13BFX120) 国家食品药品监督管理总局委托项目《生物制品数据保护策略研究》
【分类号】：R951
，

本文编号：1995750